Lundbeck announced the launch of Circadin® for insomnia in Germany. Circadin® was approved by the European Commission on 29 June 2007, and Lundbeck expects to launch the product in another 14 markets during 2008. "We are very happy to have launched Circadin® in Germany, which is the first of the 15 markets in Europe where Lundbeck expects to roll out Circadin® during 2008...
...Circadin® is the first and only IP-protected, prolonged-release, melatonin-containing prescription drug approved in the EU. Melatonin is a naturally occurring hormone produced by the pineal gland; and it has a pivotal role in the regulation of circadian rhythms and sleep... Lundbeck's Press Release -
